Cases & Deals

JumpStart invests in TheraVasc Inc.

Clients JumpStart Inc.

Jones Day advised JumpStart Inc. in connection with its purchase of a Secured Convertible Promissory Note in a private placement by TheraVasc Inc., a company focused on the development of novel vascular therapies with decreased risks through the repositioning of drugs with known safety profiles.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.